CHWY vs ELAN vs UL Stock Comparison

Chewy, Elanco Animal Health and Unilever Prices as of Nov 13, 2026 Peers: Industry group
CHWY Chewy, Inc.
$22.51 +8.0% 1M -32.8% 1Y
Market cap
$8.79B
P/E
32.1x
Revenue (TTM)
$13.07B
Div. yield
–
Packaged Foods Consumer Staples
3 wins
UL Unilever Plc
$66.21 +3.7% 1M -2.4% 1Y
Market cap
$146.07B
P/E
–
Revenue (TTM)
$64.28B
Div. yield
–
Packaged Foods Consumer Staples
4 wins

Head to Head

9 decided of 12

Unilever leads on 4 of the 12 questions below (Unilever 4, Chewy 3, Elanco Animal Health 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCHWYELANULLeader
Larger companyMarket capitalisation $8.79B $13.25B $146.07B UL
Cheaper on earningsLower P/E, profitable companies only 32.1x -90.2x — –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 30.0x 23.7x 19.6x UL
Faster revenue growthRevenue growth, trailing twelve months +5.9% +12.1% -2.6% ELAN
More profitableNet margin, trailing twelve months 2.1% -2.9% — CHWY
Better return on capitalReturn on invested capital — 6.9% — –
Less leveragedLower net debt / EBITDA 0.0x 2.3x — CHWY
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -32.8% +21.8% -2.4% ELAN
Better 5-year returnAnnualised price return, 5 years -21.8%/yr -4.1%/yr +2.3%/yr UL
Less volatileAnnualised volatility, 1 year 47.7% 43.4% 25.4% UL
Higher overall scoreMean of the five percentile scores vs peers 70/100 69/100 21/100 CHWY

Percentile Scorecard

CHWYELANUL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCHWYELANUL
Valuation 56 #21 of 46 92 #52 of 660 0 #46 of 46
Growth 90 #5 of 42 67 #208 of 619 –
Profitability 60 #17 of 41 85 #90 of 595 –
Financial Health 57 #21 of 48 31 #473 of 683 40 #29 of 48
Shareholder Returns 85 #6 of 34 73 #126 of 459 21 #27 of 34
Overall 70 69 21
  • CHWY ranked among 48 companies in Branded Foods
  • ELAN ranked among 695 companies in Pharmaceuticals and Biotechnology
  • UL ranked among 48 companies in Branded Foods

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCHWYELANULSPY
1 month +8.0%+18.8%+3.7% -2.0%
3 months +0.4%+13.2%+6.6% -2.8%
6 months +5.8%+34.9%+17.7% +2.0%
Year to date -31.9%+18.4%+1.2% +10.6%
1 year -32.8%+21.8%-2.4% +12.2%
3 years +11.6%+136.2%+20.6% +68.1%
3 years, per year +3.7%+33.2%+6.4% +18.9%
5 years -70.7%-18.9%+12.2% +61.4%
5 years, per year -21.8%-4.1%+2.3% +10.1%
10 years ——+47.7% +248.5%
10 years, per year ——+4.0% +13.3%

Risk

MeasureCHWYELANULSPY
Volatility, 1Y 47.7%43.4%25.4% 13.6%
Downside volatility, 1Y 48.1%43.7%24.8% 13.9%
Beta vs S&P 500, 1Y 0.821.32-0.02 1.00
Return / volatility, 1Y -0.690.50-0.10 0.90
Max drawdown, 5Y -80.3%-75.0%-26.2% -25.4%
From 52-week high -36.4%-0.2%-11.2% -3.2%
52-week high $35.37$26.84$74.59 $779.14
52-week low $17.51$19.80$55.05 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCHWYELANUL
P/E now vs peer median 33.4xmedian 18.9x -91.1xmedian 17.0x —median 18.9x
P/S now vs peer median 0.7xmedian 0.9x 2.6xmedian 8.4x 2.2xmedian 0.9x
EV/EBITDA now vs peer median 19.1xmedian 12.8x 11.8xmedian 14.6x —median 12.8x
P/FCF now vs peer median 15.9xmedian 13.7x 32.8xmedian 19.0x —median 13.7x
P/B now vs peer median 24.4xmedian 1.6x 2.0xmedian 2.0x 7.8xmedian 1.6x
PEG now vs peer median 0.44median 0.70 -1.82median 0.43 —median 0.70

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCHWYELANUL
Revenue $13.07B $5.15B $64.28B
Gross profit $3.91B $2.89B –
Operating income $328.20M $720.00M –
Net income $273.70M -$147.00M –
Free cash flow $568.10M $408.00M –
R&D – $381.00M –
EPS (diluted) $0.67 $-0.29 –
Cash & equivalents $611.00M $465.00M $5.40B
Total debt $591.70M $3.71B $27.38B
Shares (diluted) 410.10M 506.50M 2.20B
Enterprise value $6.08B $11.29B $97.52B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCHWYELANUL
P/E 33.4x -91.1x –
P/FCF 15.9x 32.8x –
P/Operating cash flow 12.6x 21.8x –
P/S 0.7x 2.6x 2.2x
P/B 24.4x 2.0x 7.8x
P/Tangible book 40.9x 3.7x -92.6x
EV/EBITDA 19.1x 11.8x –
EV/EBIT 27.5x 23.1x –
EV/Revenue 0.7x 3.2x 2.5x
EV/FCF 15.9x 40.8x –
EV/Operating cash flow 12.6x 27.1x –
PEG (3Y EPS CAGR) 0.44 -1.82 –

Growth

14 metrics
MetricCHWYELANUL
Revenue growth (1Y) 5.9% 12.1% -2.6%
Revenue CAGR (3Y) 6.4% 5.6% 147.1%
Gross profit growth (1Y) 7.6% 14.6% –
Gross profit CAGR (3Y) 8.5% 4.9% –
Operating income growth (1Y) 102.0% 20.6% –
Operating income CAGR (3Y) 139.1% 41.2% –
Net income growth (1Y) 81.1% -508.3% –
Net income CAGR (3Y) 73.8% 49.5% –
EPS growth (1Y) 89.2% -500.5% –
EPS CAGR (3Y) 76.8% 50.0% –
Operating cash flow growth (1Y) 17.3% -2.4% –
Operating cash flow CAGR (3Y) 10.9% 69.1% –
Free cash flow growth (1Y) 22.7% 10.9% –
Free cash flow CAGR (3Y) 18.6% 117.8% –

Profitability

14 metrics
MetricCHWYELANUL
Gross margin 29.9% 56.2% –
EBITDA margin 3.6% 27.5% –
Operating margin 2.5% 14.0% –
Pretax margin 2.7% -1.8% –
Net margin 2.1% -2.9% –
FCF margin 4.3% 7.9% –
Operating cash flow margin 5.5% 11.9% –
Return on equity 69.0% -2.2% –
Return on assets 7.8% -1.1% –
Return on invested capital – 6.9% –
Return on capital employed 24.9% 6.2% –
Asset turnover 3.7x 0.4x 0.8x
Cash conversion (OCF / net income) 2.6x -4.2x –
Stock comp / revenue 2.3% 1.5% –

Financial Health

11 metrics
MetricCHWYELANUL
Debt / assets 15.8% 27.8% 31.2%
Debt / equity 1.6x 0.6x 1.5x
Net debt / EBITDA 0.0x 2.3x –
Debt / FCF 1.0x 9.1x –
Liabilities / assets 90.1% 50.3% 79.0%
Equity / assets 9.9% 49.7% 21.0%
Interest coverage – 2.8x –
Current ratio 0.8x 2.1x 0.7x
Quick ratio 0.4x 0.9x 0.7x
Cash ratio 0.3x 0.3x 0.4x
Altman Z-score 4.83 1.72 –

Shareholder Returns

7 metrics
MetricCHWYELANUL
Dividend yield – – 3.2%
Net buyback yield 5.6% -0.3% –
Shareholder yield 5.6% -0.3% 3.2%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCHWYELANUL
Forward P/E 30.0xFY2026 23.7xFY2026 19.6xFY2026
EPS, next fiscal year $0.75FY2026 $1.13FY2026 $3.37FY2026
EPS growth, next FY +44.2%FY2026 +20.2%FY2026 -7.9%FY2026
EPS growth, the year after +49.3% +22.1% +8.6%
Revenue, next fiscal year $12.87BFY2026 $4.82BFY2026 $54.67BFY2026
Revenue growth, next FY +2.1%FY2026 +2.4%FY2026 -8.9%FY2026
Revenue growth, the year after +5.5% +19.4% +8.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCHWYELANUL
Held by institutions 100.0% 100.0% 11.8%
Institutions holding 513 526 1,194
Change in shares held, QoQ -0.4% +4.4% +7.2%
Institutions buying 278 246 576
Institutions selling 156 211 443
Buyers to sellers 1.78 1.17 1.30

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CHWYELANUL
CHWY 1.00 0.24 0.22
ELAN 0.24 1.00 0.22
UL 0.22 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CHWY, ELAN and UL?

Unilever (UL) is the largest by market capitalisation: Chewy (CHWY) $8.79B, Elanco Animal Health (ELAN) $13.25B, Unilever (UL) $146.07B.

Which company is growing faster?

Elanco Animal Health (ELAN) grew revenue fastest over the trailing twelve months: Chewy (CHWY) +5.9%, Elanco Animal Health (ELAN) +12.1%, Unilever (UL) -2.6%.

Which company is more profitable?

Chewy (CHWY) has the highest net margin (Chewy (CHWY) 2.1%, Elanco Animal Health (ELAN) -2.9%).

Which stock has performed better?

Over the past year Elanco Animal Health (ELAN) returned the most: Chewy (CHWY) -32.8%, Elanco Animal Health (ELAN) +21.8%, Unilever (UL) -2.4%. Over five years, Unilever (UL) compounded fastest (Chewy (CHWY) -21.8%/yr, Elanco Animal Health (ELAN) -4.1%/yr, Unilever (UL) +2.3%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Unilever (UL) has been the steadiest (Chewy (CHWY) 47.7%, Elanco Animal Health (ELAN) 43.4%, Unilever (UL) 25.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CHWY, ELAN and UL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Unilever (UL) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.